Vaseem Mahboob - Jul 17, 2025 Form 4 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Role
Chief Financial Officer
Signature
/s/ Vaseem Mahboob
Stock symbol
KMTS
Transactions as of
Jul 17, 2025
Transactions value $
$0
Form type
4
Date filed
7/21/2025, 05:14 PM
Previous filing
Mar 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mahboob Vaseem Chief Financial Officer C/O KESTRA MEDICAL TECHNOLOGIES, LTD., 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND /s/ Vaseem Mahboob 2025-07-21 0001655157

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KMTS Common Shares Award $0 +22.1K +148.67% $0.00 36.9K Jul 17, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KMTS Options 159K Jul 17, 2025 Common Shares 159K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest 7,353 on July 17, 2026, 7,353 on July 17, 2027 and 7,354 on July 17, 2028.
F2 Includes 79,500 options that will vest on March 6, 2026, and the remaining 79,500 will vest monthly over the following year.

Remarks:

Exhibit 24.1 - Power of Attorney